Publication number: 20250206752
Abstract: A compound having the following structure of Formula (I): or a stereoisomer of the compound, tautomer of the compound, pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R8, A, X, Z, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.
Type:
Application
Filed:
February 7, 2025
Publication date:
June 26, 2025
Inventors:
Payal Chatterjee, Mark J. Chicarelli, Michael L. Conner, John Fischer, Jennifer Fulton, Ravi Kumar Jalluri, Hailey J. Knox, Vijay Kumar, Bradley J. Newhouse, Martha E. Rodriguez, Leah J. Salituro, Aaron C. Smith, Lee M. Stunkard, Yeyun Zhou, Paul R. Carlson, Scott W. Niman, Patrick J. Sutter, John I. Trujillo, Logan E. Vine, Brooklynn Venteicher